US$ 26.14
glp 1 agonists for type 2 diabetes New Developments in Pharmacological Treatment of Obesity and Diabetes—Beyond and within GLP-1 Receptor Glucagon-Like Peptide 1 Receptor Agonists
Description
Taha MB, Yahya T, Satish P, et al

Gastrointestinal discomfort : Symptoms like bloating and indigestion may occur

Triple agonists (GLP-1/GIP/glucagon) further extend these effects by enhancing energy expenditure and reducing hepatic fat and inflammation

Inhibiting neuronal apoptosis and neurotoxicity Neuronal apoptosis, induced by A and stress, is regard as a physiolopathologic marker in AD brain (190)

Blonde L, Berard L, Saremi A, Huang Y, Aroda VR, Raccah D

Uninsured or underinsured patients may qualify for patient-assistance programs that offer medication at low or no cost
